SUSQUEHANNA INTERNATIONAL GROUP, LLP - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$23,678
+6.0%
16,793
+9.8%
0.00%
Q4 2022$22,338
-94.8%
15,300
-84.7%
0.00%
Q3 2022$427,000
-7.0%
99,900
-15.6%
0.00%
Q2 2022$459,000
-15.3%
118,400
+4.0%
0.00%
Q1 2022$542,000
+13.4%
113,800
-13.2%
0.00%
Q4 2021$478,000
+41.0%
131,116
+210.0%
0.00%
Q3 2021$339,000
-60.5%
42,300
-44.2%
0.00%
Q2 2021$859,000
-10.7%
75,803
-27.1%
0.00%
Q1 2021$962,000104,0110.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 831,625$7,693,0001.42%
BVF INC/IL 3,094,174$28,621,0001.07%
SECTORAL ASSET MANAGEMENT INC 647,556$5,990,0000.45%
Logos Global Management LP 470,000$4,348,0000.42%
AlphaCentric Advisors LLC 92,402$855,0000.29%
SILVERARC CAPITAL MANAGEMENT, LLC 28,570$264,0000.14%
Opaleye Management Inc. 103,600$958,0000.14%
Monashee Investment Management LLC 84,802$784,0000.12%
KETTLE HILL CAPITAL MANAGEMENT, LLC 93,900$869,0000.08%
Ikarian Capital, LLC 155,599$1,439,0000.05%
View complete list of VIRACTA THERAPEUTICS INC shareholders